Psychedelic Clinical Trial: Enroll in Psychedelic Research Today
Mar 23, 2020 · Follow these steps to join an ongoing psychedelic clinical trial today. Use the map and list to search for current research studies near you.
Safety and Efficacy of Repeated Low-Dose LSD for ADHD …
Mar 19, 2025 · To our knowledge, this is the first double-blind, placebo-controlled randomized clinical trial to investigate effects of repeated low-dose (20 μg) LSD administration in adults …
MindMed's Phase 3 Trials of MM120 for Generalized Anxiety …
Feb 10, 2025 · MindMed has officially dosed the first patient in Panorama, its second phase 3 clinical trial evaluating MM120, a lysergide D-tartrate (LSD) treatment for generalized anxiety …
Lysergic Acid Diethylamide-Assisted Therapy in Patients With
Feb 1, 2023 · Background: This study aimed to investigate the efficacy and safety of lysergic acid diethylamide (LSD)-assisted therapy in patients who experienced anxiety with or without …
Just 1 dose of LSD could relieve anxiety for months, trial finds
Sep 5, 2025 · An early trial with about 200 people tested the effects of LSD on generalized anxiety disorder and found promising results.
MindMed Announces First Patient Dosed in Phase 3 Voyage Study …
Dec 16, 2024 · MM120 ODT (lysergide D-tartrate or LSD) is a synthetic ergotamine belonging to the group of classic, or serotonergic, psychedelics which acts as a partial agonist at human …
LSD-Based Med Safe, Effective for Anxiety in Phase 2B Trial
Sep 8, 2025 · Compared with placebo, a single application of the LSD-based medication MM120 is linked to rapidly reduced anxiety and depressive symptoms in adults with generalized …
MindMed to lead first LSD Phase 3 trials for anxiety
Oct 25, 2024 · As MindMed advances its novel LSD therapy to a Phase 3 trial, the company aims to transform treatment for generalized anxiety disorder. In August 2024, MDMA, which is …
MindMed Initiates Second Phase 3 Trial of Psychedelic MM120 for ...
Feb 4, 2025 · Mind Medicine (MindMed), a late-stage clinical biopharmaceutical company, announced the initiation of Panorama, its second phase 3 clinical trial evaluating MM120 ODT, …
Phase 2 Study Suggests Single-Dose LSD May Help Reduce …
Nov 28, 2025 · Single-Dose LSD May Help Reduce Anxiety Symptoms, as noted in a Phase 2 study, showing potential promise for anxiety relief through psychedelic research.